BIOFILCHEM vs ORTINGLOBE: Stock Comparison

Biofil Chemicals & Pharmaceuticals Limited vs ORTIN GLOBAL LIMITED

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Biofil Chemicals & Pharmaceuticals Limited is the larger company by market capitalisation. Biofil Chemicals & Pharmaceuticals Limited shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Biofil Chemicals & Pharmaceuticals Limited and ORTIN GLOBAL LIMITED on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BIOFILCHEM is more favourable on 8 of 10 scored metrics and ORTINGLOBE on 1These counts are context-free and are not an overall rating.

Key Differences

Market Cap
BIOFILCHEM is the larger company
₹53 Cr vs ₹12 Cr
EPS
BIOFILCHEM has higher earnings per share
₹1.71 vs ₹-1.13
Revenue Growth (TTM YoY)
BIOFILCHEM has faster revenue growth
-9.3% vs -76.86%
EPS Growth (TTM YoY)
BIOFILCHEM has faster EPS growth
10.8% vs 0%
Qtr Sales Growth
ORTINGLOBE has stronger quarterly sales growth
0% vs -9.34%
Qtr Profit Growth
BIOFILCHEM has stronger quarterly profit growth
5% vs 0%
ROE
BIOFILCHEM has a higher ROE
13.8% vs -59.85%
ROCE
BIOFILCHEM has a higher ROCE
15.8% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBIOFILCHEMORTINGLOBE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBIOFILCHEMORTINGLOBE
Live Price₹32.64₹18.02
Day Change-0.55%0.5%
Volume4,04848,801
52-Week High₹46.34₹21.3
52-Week Low₹25.6₹11
Distance from 52W High-29.56%-15.4%

Valuation

MetricBIOFILCHEMORTINGLOBE
Market Cap₹53 Cr₹12 Cr
EPS₹1.71₹-1.13
Book Value₹13.21₹2.43
Dividend Yield0%0%

Growth

MetricBIOFILCHEMORTINGLOBE
Revenue Growth (TTM YoY)-9.3%-76.86%
EPS Growth (TTM YoY)10.8%0%
Qtr Sales Growth-9.34%0%
Qtr Profit Growth5%0%

Profitability & Leverage

MetricBIOFILCHEMORTINGLOBE
ROE13.8%-59.85%
ROCE15.8%0%
Net Margin9.81%-529.87%
Operating Margin2.29%
Debt to Equity0.14x0.81x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBIOFILCHEMORTINGLOBE
Promoter Holding46.79%1.23%
FII Holding0%1.8% 0.12 pp
DII Holding0.08%0%
Public Holding53.13%96.96% 0.13 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Biofil Chemicals & Pharmaceuticals Limited and ORTIN GLOBAL LIMITED.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.